Impact News +++ ABIONYX Pharma Is Launching a Capital Increase With Cancellation of Preferential Subscription Rights in... (Business Wire) +++ ABIONYX Aktie -4,27%

Gewinn & Umsatz News zur INSULET Aktie

>INSULET Aktienkurs

246.1 EUR -0.8% (Tradegate)

Ask: 248.3 EUR / 40 Stück

Bid: 243.3 EUR / 41 Stück

Tagesumsatz: 18 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INSULET Aktie über LYNX handeln

Intraday

1 Jahr

>INSULET Performance

1 Woche: -4,5%

1 Monat: -13,6%

3 Monate: -11,7%

6 Monate: -7,4%

1 Jahr: -3,3%

laufendes Jahr: -2,2%

>INSULET Aktie

Name:

INSULET CORP. DL -,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US45784P1012 / A0MQX8

Symbol/ Ticker:

GOV (Frankfurt) / PODD (NASDAQ)

Kürzel:

FRA:GOV, ETR:GOV, GOV:GR, NASDAQ:PODD

Index:

Webseite:

https://www.insulet.com/

Profil:

Insulet Corporation is a leading medical device co..
>Volltext..

Marktkapitalisierung:

17626.57 Mio. EUR

Unternehmenswert:

17859.91 Mio. EUR

Umsatz:

2148.09 Mio. EUR

EBITDA:

460.72 Mio. EUR

Nettogewinn:

209.71 Mio. EUR

Gewinn je Aktie:

2.98 EUR

Schulden:

878.43 Mio. EUR

Liquide Mittel:

645.13 Mio. EUR

Operativer Cashflow:

454.59 Mio. EUR

Bargeldquote:

1.17

Umsatzwachstum:

20.62%

Gewinnwachstum:

-44.5%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 242.626 USD.

Suchwörter:

INSULET

Letzte Datenerhebung:

17.12.25

>INSULET Kennzahlen

Aktien/ Unternehmen:

Aktien: 70.35 Mio. St.

Frei handelbar: 99.58%

Leerverk. Aktien: 2.96%

Rückkaufquote: 0.14%

Mitarbeiter: 3900

Umsatz/Mitarb.: 0.45 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 31.54%

Bewertung:

KGV: 85.25

KGV lG: 60.25

KUV: 8.54

KBV: 14.93

PEG-Ratio: -

EV/EBITDA: 38.76

Rentabilität:

Bruttomarge: 72.11%

Gewinnmarge: 9.76%

Operative Marge: 17.32%

Managementeffizenz:

Gesamtkaprendite: 8.13%

Eigenkaprendite: 19.68%

>INSULET Peer Group

Es sind 599 Aktien bekannt.

>INSULET Chart & Kurs - NASDAQ

>INSULET Gewinn & Umsatz News

06.11.25 - 18:48	Insulet Q3 Profit Rises (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corporation (PODD) Thursday reported third-quarter net income of $87.6 million or $1.24 per share, compared with $77.5 million, or $1.08 per share in the prior year.......

06.11.25 - 12:54	Insulet shares rise 4% as Q3 results top estimates, company raises guidance (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

26.08.25 - 14:42	Insulet Stock: Analyst Estimates & Ratings (Barchart)
	Insulet has significantly outpaced the broader market over the past year, and analysts remain very bullish on the stock's prospects....

08.08.25 - 04:24	Insulet Corp. Q2 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released a profit for second quarter that Decreased from the same period last year but beat the Street estimates.The company's bottom line came in at $2......

24.07.25 - 14:18	What to Expect From Insulets Q2 2025 Earnings Report (Barchart)
	Insulet is expected to release its second-quarter earnings next month, with analysts anticipating double-digit bottom-line growth....

09.05.25 - 00:36	Insulet Posts Mixed Q1 Results With Revenue Growth And Lower Earnings (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corporation (PODD), a medical device company, on Thursday posted its first quarter results for 2025. With a net income of $35.4 million for the first quarter of 2025......

28.04.25 - 14:48	Heres What to Expect From Insulets Next Earnings Report (Barchart)
	Insulet is set to release its first-quarter results next month, and analysts expect a double-digit earnings growth....

20.03.25 - 03:24	Insulet′s RADIANT Trial Results Highlight Significant Glycemic Benefits From Omnipod 5 Transition (AFX)
	WASHINGTON (dpa-AFX) - The RADIANT trial conducted by Insulet Corp. (PODD) highlighted significant glycemic improvements with the use of the Omnipod 5 Automated Insulin Delivery System. These impr......

25.02.25 - 13:48	Insulet Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock's prospects....

20.02.25 - 22:36	Insulet Corp. Profit Retreats In Q4 (AFX)
	WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) announced earnings for fourth quarter that decreased from the same period last yearThe company's bottom line came in at $100.7 million, or $1.39 per sha......

27.01.25 - 14:48	Earnings Preview: What to Expect From Insulets Report (Barchart)
	Insulet is scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a double-digit profit decline....

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram